Effectiveness of rifampin in eradicating the meningococcal carrier state in a relatively closed population: emergence of resistant strains.
D000328:Adult; D001219:Aspartate Aminotransferases / Q000097:blood; D002353:Carrier State; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D008585:Meningitis, Meningococcal / Q000517:prevention & control*; D008826:Microbial Sensitivity Tests; D008887:Military Medicine; D009345:Neisseria meningitidis / Q000187:drug effects*; D012293:Rifampin / Q000494:pharmacology / Q000627:therapeutic use*; D012703:Serotyping
D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D012293:Rifampin